SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Filed pursuant to Section 12, 13, or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 27, 1996
COOPER LABORATORIES, INC. STOCKHOLDERS' LIQUIDATING TRUST
------------------------------------------------
(Exact name of issuer as specified in charter)
DELAWARE 1-8597 94-6622784
-------- ------ ----------
(State or Other Jurisdiction Commission (I.R.S. Employer
of Incorporation or file number Identification
Organization) Number)
The First National Bank of Boston, Corporate Trust,
150 Royall Street, Canton, MA 02021
------------------------------------------------
(Address of principal executive offices)
(617) 575-2075
--------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE>
Item 5. Other Events.
The remaining assets (the "Trust Estate") of the Cooper Laboratories,
Inc. Stockholders' Liquidating Trust, a Delaware liquidating trust (the
"Trust") in 1992 have been reduced to cash, and a distribution has been paid to
creditors in satisfaction of substantially all claims of creditors allowed
against the Trust Estate. In January 1996, Michael B. Joseph, Esquire, the
bankruptcy trustee (the "Bankruptcy Trustee"), filed a Final Report and Account
of the Administration of the Estate (the "Final Report") with the Bankruptcy
Court. Among other things, the Final Report provides for the distribution of the
remaining funds in the Trust Estate to creditors and the abandonment of all
remaining unliquidated property of the Trust Estate. In March 1996, a hearing
was held by the Bankruptcy Court at which the Court entered a final decree
approving final distribution of the remaining funds. In July 1996, the
Bankruptcy Trustee filed a supplemental final report indicating that all funds
had been distributed and that the bankruptcy case could be closed. The Trust is
being dissolved on the date of this Form 8-K.
As previously projected and reported by the Trust, after the allowable
claims of creditors were paid as described above, there were no remaining assets
in the Trust Estate available for distribution to the beneficiaries of the
Trust. Accordingly, beneficiaries of the Trust will not receive any distribution
from the Trust.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
COOPER LABORATORIES, INC. STOCKHOLDERS'
LIQUIDATING TRUST
Date: September 27, 1996 By: /s/ Michael B. Joseph
-----------------------
Michael B. Joseph, Esquire,
Bankruptcy Trustee
-3-
